Article
Giant disseminated condylomatosis in SLE
Registro en:
PINTO, L. C. et al. Giant disseminated condylomatosis in SLE. Lupus, v. 21, n. 3, p. 332-334, 2012.
1477-0962
10.1177/0961203311421207
Autor
Pinto, Licia Costa
Grassi, Maria Fernanda Rios
Ramos, Karina Serravalle
Travessa, A. C. V
Gallazzi, Viviana Nilla Olavarria
Santiago, Mittermayer Barreto
Resumen
Introduction: Females with systemic lupus erythematosus (SLE) have higher prevalence of
human papillomavirus (HPV) infection, which can lead to the development of warts.
Herein we report the first case of giant disseminated condylomatosis (GDC) in a SLE
female on mycophenolate mofetil (MMF). Case report: The patient, a 33-year-old, Black
female, was diagnosed with SLE during her first pregnancy in 2003 based on the features of
arthritis, skin rash, seizures, nephritis and presence of antinuclear antibodies. Her pregnancy
resulted in preterm delivery of a stillborn fetus at 28 weeks. Since that time she has been
treated with steroids and different regimens of immunosuppressive drugs such as cyclophosphamide,
azathioprine and lately MMF. In the last few years she presented GDC involving the
genital area in addition to skin on the lower abdomen. Topical therapy with trichloroacetic
acid, imiquimod and podophyllin was only partially effective. Different types of HPV were
identified in the lesions, being HPV-11 in abdomen, HPV 6, 11, 42 in vulva, HPV-6, 11 in
vagina and HPV-6, 11 in endocervix. Conclusions: GDC may be a complication of SLE,
secondary to the disease itself, its treatment or other factors not yet identified.